ABC Farma - Artificial Intelligence Doctor
A new Medtronic press release dated September 15, 2025 announced the launch of a global pivotal trial named ELEVATE‑HFpEF (ClinicalTrials.gov: NCT06678841). The study evaluates a “new approach to pacing the heart” in patients with HFpEF, based on conduction system pacing.
However, this announcement does not confirm the development or regulatory submission of a fully leadless intraseptal/LBBAP pacemaker nor a modular multi‑chamber Micra system. It represents progress in conduction‑system pacing, but not the specific whole‑heart leadless platform that was being monitored.
I will continue monitoring for any regulatory filings, press releases, or clinical trial disclosures that explicitly reference a leadless intraseptal/LBBAP system or a modular multi‑chamber Micra device from Medtronic.